Dr. Raymond Woosley is the founding President and Chairman of the Board of The Critical Path Institute (C-Path). Dr. Woosley is also the Director of the Arizona Center for Education and Research on Therapeutics.

Prior, Dr. Woosley was Vice President for The University of Arizona (UA) Health Sciences Center and Dean of the UA College of Medicine. He was Associate Dean for Clinical Research and Chair of the Department of Pharmacology at Georgetown University School of Medicine. Dr. Woosley was a professor at Vanderbilt University Medical School and the first US scientist for Glaxo's initial US operations.

Dr. Woosley earned his Ph.D. in Pharmacology from the University of Louisville, his M.D. from the University of Miami and completed post-doctoral training in pharmacology, internal medicine and clinical pharmacology. His research has been published in over 265 peer-reviewed publications and 50 book chapters.

Dr. Woosley is a member of the National Academy of Science's Institute of Medicine's Drug Forum. Dr. Woosley is a Past-President of the Association for Medical School Pharmacology and the American Society for Clinical Pharmacology and Therapeutics. He has served on numerous boards including the US Pharmacopeia. He is a member of the Biodesign Institute at Arizona State University, the University of Arizona's Sarver Heart Center and the Bio5 Institute.